Actual Medicinal Product (AMP) Sevikar 20mg/5mg tablets (CST Pharma Ltd)

Stability Information

(Some stability information inherited from generic)

Stability
compatible_special_measures logo Lack of data and/or stability concerns exist. MCA use may be acceptable but is likely to be off-label and require mitigation measures. Keep medicines in MCAs for the shortest time necessary. Generally, up to 5 weeks maximum unless otherwise specified, or up to 8 weeks if the MCA is airtight (sealed). Consider the risk of potency loss or dose variability and monitor for changes in efficacy or adverse effects after MCA initiation.
Notes

Moisture sensitive medicine. Store in airtight (sealed) MCA.  Light sensitive medicine. Store in light resistant container. No stability data in MCAs available.

Provenance

This recommendation is based on the products Sevikar 20mg/5mg tablets (Daiichi Sankyo UK Limited) and olmesartan medoxomil/amlodipine 20mg/5mg tablets (Accord Healthcare Limited).

Generic
Olmesartan + Amlodipine
Formulation
Olmesartan medoxomil 20mg / Amlodipine 5mg tablets
  • Olmesartan + Amlodipine
    • Olmesartan medoxomil 20mg / Amlodipine 5mg tablets

      • Sevikar 20mg/5mg tablets (CST Pharma Ltd)